0.023180 0.000000 0.000000 0.000000 0.011663 0.000000 0.000000 0.000000 0.015494 0.00000 0.00000 0.00000 Klabunde, T. Petrassi, H.M. Oza, V.B. Kelly, J.W. Sacchettini, J.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 43.140 85.740 64.540 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C14 H11 Cl2 N O2 296.149 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID DICLOFENAC non-polymer C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 7 312 321 10.1038/74082 10742177 Rational design of potent human transthyretin amyloid disease inhibitors. 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 293 1 IMAGE PLATE 1998-10-10 MACSCIENCE SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RU200 13420.968 TRANSTHYRETIN 2 man polymer 296.149 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID 1 syn non-polymer 18.015 water 52 nat water PREALBUMIN no no GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWK ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWK ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli 1 2.22 44.65 VAPOR DIFFUSION, HANGING DROP 7.4 potassium chloride potassium phosphate ammonium sulfate, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K 293 repository Initial release Version format compliance Derived calculations Version format compliance 1 0 2001-01-23 1 1 2008-04-27 1 2 2011-07-13 HUMAN TRANSTHYRETIN (PREALBUMIN) CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID RCSB Y RCSB 2000-01-23 REL DIF 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID HOH water DIC 1 2 DIF DIF 125 B WAT 100 3 HOH HOH 125 A WAT 101 3 HOH HOH 126 A WAT 104 3 HOH HOH 127 A WAT 106 3 HOH HOH 128 A WAT 107 3 HOH HOH 129 A WAT 110 3 HOH HOH 130 A WAT 111 3 HOH HOH 131 A WAT 113 3 HOH HOH 132 A WAT 114 3 HOH HOH 133 A WAT 115 3 HOH HOH 134 A WAT 118 3 HOH HOH 135 A WAT 119 3 HOH HOH 136 A WAT 120 3 HOH HOH 137 A WAT 123 3 HOH HOH 138 A WAT 124 3 HOH HOH 139 A WAT 126 3 HOH HOH 140 A WAT 128 3 HOH HOH 141 A WAT 129 3 HOH HOH 142 A WAT 134 3 HOH HOH 143 A WAT 135 3 HOH HOH 144 A WAT 136 3 HOH HOH 145 A WAT 137 3 HOH HOH 146 A WAT 138 3 HOH HOH 147 A WAT 139 3 HOH HOH 148 A WAT 141 3 HOH HOH 149 A WAT 142 3 HOH HOH 150 A WAT 145 3 HOH HOH 151 A WAT 146 3 HOH HOH 152 A WAT 148 3 HOH HOH 153 A WAT 149 3 HOH HOH 154 A WAT 151 3 HOH HOH 155 A WAT 102 3 HOH HOH 126 B WAT 103 3 HOH HOH 127 B WAT 105 3 HOH HOH 128 B WAT 108 3 HOH HOH 129 B WAT 109 3 HOH HOH 130 B WAT 112 3 HOH HOH 131 B WAT 116 3 HOH HOH 132 B WAT 117 3 HOH HOH 133 B WAT 121 3 HOH HOH 134 B WAT 122 3 HOH HOH 135 B WAT 125 3 HOH HOH 136 B WAT 127 3 HOH HOH 137 B WAT 130 3 HOH HOH 138 B WAT 131 3 HOH HOH 139 B WAT 132 3 HOH HOH 140 B WAT 133 3 HOH HOH 141 B WAT 140 3 HOH HOH 142 B WAT 143 3 HOH HOH 143 B WAT 144 3 HOH HOH 144 B WAT 147 3 HOH HOH 145 B WAT 150 3 HOH HOH 146 B n 1 1 A n 2 2 A n 3 3 A n 4 4 A n 5 5 A n 6 6 A n 7 7 A n 8 8 A n 9 9 A CYS 10 n 10 CYS 10 A PRO 11 n 11 PRO 11 A LEU 12 n 12 LEU 12 A MET 13 n 13 MET 13 A VAL 14 n 14 VAL 14 A LYS 15 n 15 LYS 15 A VAL 16 n 16 VAL 16 A LEU 17 n 17 LEU 17 A ASP 18 n 18 ASP 18 A ALA 19 n 19 ALA 19 A VAL 20 n 20 VAL 20 A ARG 21 n 21 ARG 21 A GLY 22 n 22 GLY 22 A SER 23 n 23 SER 23 A PRO 24 n 24 PRO 24 A ALA 25 n 25 ALA 25 A ILE 26 n 26 ILE 26 A ASN 27 n 27 ASN 27 A VAL 28 n 28 VAL 28 A ALA 29 n 29 ALA 29 A VAL 30 n 30 VAL 30 A HIS 31 n 31 HIS 31 A VAL 32 n 32 VAL 32 A PHE 33 n 33 PHE 33 A ARG 34 n 34 ARG 34 A LYS 35 n 35 LYS 35 A ALA 36 n 36 ALA 36 A ALA 37 n 37 ALA 37 A ASP 38 n 38 ASP 38 A ASP 39 n 39 ASP 39 A THR 40 n 40 THR 40 A TRP 41 n 41 TRP 41 A GLU 42 n 42 GLU 42 A PRO 43 n 43 PRO 43 A PHE 44 n 44 PHE 44 A ALA 45 n 45 ALA 45 A SER 46 n 46 SER 46 A GLY 47 n 47 GLY 47 A LYS 48 n 48 LYS 48 A THR 49 n 49 THR 49 A SER 50 n 50 SER 50 A GLU 51 n 51 GLU 51 A SER 52 n 52 SER 52 A GLY 53 n 53 GLY 53 A GLU 54 n 54 GLU 54 A LEU 55 n 55 LEU 55 A HIS 56 n 56 HIS 56 A GLY 57 n 57 GLY 57 A LEU 58 n 58 LEU 58 A THR 59 n 59 THR 59 A THR 60 n 60 THR 60 A GLU 61 n 61 GLU 61 A GLU 62 n 62 GLU 62 A GLN 63 n 63 GLN 63 A PHE 64 n 64 PHE 64 A VAL 65 n 65 VAL 65 A GLU 66 n 66 GLU 66 A GLY 67 n 67 GLY 67 A ILE 68 n 68 ILE 68 A TYR 69 n 69 TYR 69 A LYS 70 n 70 LYS 70 A VAL 71 n 71 VAL 71 A GLU 72 n 72 GLU 72 A ILE 73 n 73 ILE 73 A ASP 74 n 74 ASP 74 A THR 75 n 75 THR 75 A LYS 76 n 76 LYS 76 A SER 77 n 77 SER 77 A TYR 78 n 78 TYR 78 A TRP 79 n 79 TRP 79 A LYS 80 n 80 LYS 80 A ALA 81 n 81 ALA 81 A LEU 82 n 82 LEU 82 A GLY 83 n 83 GLY 83 A ILE 84 n 84 ILE 84 A SER 85 n 85 SER 85 A PRO 86 n 86 PRO 86 A PHE 87 n 87 PHE 87 A HIS 88 n 88 HIS 88 A GLU 89 n 89 GLU 89 A HIS 90 n 90 HIS 90 A ALA 91 n 91 ALA 91 A GLU 92 n 92 GLU 92 A VAL 93 n 93 VAL 93 A VAL 94 n 94 VAL 94 A PHE 95 n 95 PHE 95 A THR 96 n 96 THR 96 A ALA 97 n 97 ALA 97 A ASN 98 n 98 ASN 98 A ASP 99 n 99 ASP 99 A SER 100 n 100 SER 100 A GLY 101 n 101 GLY 101 A PRO 102 n 102 PRO 102 A ARG 103 n 103 ARG 103 A ARG 104 n 104 ARG 104 A TYR 105 n 105 TYR 105 A THR 106 n 106 THR 106 A ILE 107 n 107 ILE 107 A ALA 108 n 108 ALA 108 A ALA 109 n 109 ALA 109 A LEU 110 n 110 LEU 110 A LEU 111 n 111 LEU 111 A SER 112 n 112 SER 112 A PRO 113 n 113 PRO 113 A TYR 114 n 114 TYR 114 A SER 115 n 115 SER 115 A TYR 116 n 116 TYR 116 A SER 117 n 117 SER 117 A THR 118 n 118 THR 118 A THR 119 n 119 THR 119 A ALA 120 n 120 ALA 120 A VAL 121 n 121 VAL 121 A VAL 122 n 122 VAL 122 A THR 123 n 123 THR 123 A ASN 124 n 124 ASN 124 A n 1 1 B n 2 2 B n 3 3 B n 4 4 B n 5 5 B n 6 6 B n 7 7 B n 8 8 B n 9 9 B CYS 10 n 10 CYS 10 B PRO 11 n 11 PRO 11 B LEU 12 n 12 LEU 12 B MET 13 n 13 MET 13 B VAL 14 n 14 VAL 14 B LYS 15 n 15 LYS 15 B VAL 16 n 16 VAL 16 B LEU 17 n 17 LEU 17 B ASP 18 n 18 ASP 18 B ALA 19 n 19 ALA 19 B VAL 20 n 20 VAL 20 B ARG 21 n 21 ARG 21 B GLY 22 n 22 GLY 22 B SER 23 n 23 SER 23 B PRO 24 n 24 PRO 24 B ALA 25 n 25 ALA 25 B ILE 26 n 26 ILE 26 B ASN 27 n 27 ASN 27 B VAL 28 n 28 VAL 28 B ALA 29 n 29 ALA 29 B VAL 30 n 30 VAL 30 B HIS 31 n 31 HIS 31 B VAL 32 n 32 VAL 32 B PHE 33 n 33 PHE 33 B ARG 34 n 34 ARG 34 B LYS 35 n 35 LYS 35 B ALA 36 n 36 ALA 36 B ALA 37 n 37 ALA 37 B ASP 38 n 38 ASP 38 B ASP 39 n 39 ASP 39 B THR 40 n 40 THR 40 B TRP 41 n 41 TRP 41 B GLU 42 n 42 GLU 42 B PRO 43 n 43 PRO 43 B PHE 44 n 44 PHE 44 B ALA 45 n 45 ALA 45 B SER 46 n 46 SER 46 B GLY 47 n 47 GLY 47 B LYS 48 n 48 LYS 48 B THR 49 n 49 THR 49 B SER 50 n 50 SER 50 B GLU 51 n 51 GLU 51 B SER 52 n 52 SER 52 B GLY 53 n 53 GLY 53 B GLU 54 n 54 GLU 54 B LEU 55 n 55 LEU 55 B HIS 56 n 56 HIS 56 B GLY 57 n 57 GLY 57 B LEU 58 n 58 LEU 58 B THR 59 n 59 THR 59 B THR 60 n 60 THR 60 B GLU 61 n 61 GLU 61 B GLU 62 n 62 GLU 62 B GLN 63 n 63 GLN 63 B PHE 64 n 64 PHE 64 B VAL 65 n 65 VAL 65 B GLU 66 n 66 GLU 66 B GLY 67 n 67 GLY 67 B ILE 68 n 68 ILE 68 B TYR 69 n 69 TYR 69 B LYS 70 n 70 LYS 70 B VAL 71 n 71 VAL 71 B GLU 72 n 72 GLU 72 B ILE 73 n 73 ILE 73 B ASP 74 n 74 ASP 74 B THR 75 n 75 THR 75 B LYS 76 n 76 LYS 76 B SER 77 n 77 SER 77 B TYR 78 n 78 TYR 78 B TRP 79 n 79 TRP 79 B LYS 80 n 80 LYS 80 B ALA 81 n 81 ALA 81 B LEU 82 n 82 LEU 82 B GLY 83 n 83 GLY 83 B ILE 84 n 84 ILE 84 B SER 85 n 85 SER 85 B PRO 86 n 86 PRO 86 B PHE 87 n 87 PHE 87 B HIS 88 n 88 HIS 88 B GLU 89 n 89 GLU 89 B HIS 90 n 90 HIS 90 B ALA 91 n 91 ALA 91 B GLU 92 n 92 GLU 92 B VAL 93 n 93 VAL 93 B VAL 94 n 94 VAL 94 B PHE 95 n 95 PHE 95 B THR 96 n 96 THR 96 B ALA 97 n 97 ALA 97 B ASN 98 n 98 ASN 98 B ASP 99 n 99 ASP 99 B SER 100 n 100 SER 100 B GLY 101 n 101 GLY 101 B PRO 102 n 102 PRO 102 B ARG 103 n 103 ARG 103 B ARG 104 n 104 ARG 104 B TYR 105 n 105 TYR 105 B THR 106 n 106 THR 106 B ILE 107 n 107 ILE 107 B ALA 108 n 108 ALA 108 B ALA 109 n 109 ALA 109 B LEU 110 n 110 LEU 110 B LEU 111 n 111 LEU 111 B SER 112 n 112 SER 112 B PRO 113 n 113 PRO 113 B TYR 114 n 114 TYR 114 B SER 115 n 115 SER 115 B TYR 116 n 116 TYR 116 B SER 117 n 117 SER 117 B THR 118 n 118 THR 118 B THR 119 n 119 THR 119 B ALA 120 n 120 ALA 120 B VAL 121 n 121 VAL 121 B VAL 122 n 122 VAL 122 B THR 123 n 123 THR 123 B n 124 124 B author_and_software_defined_assembly PISA,PQS 4 tetrameric 7360 -60 18190 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_665 -x+1,-y+1,z crystal symmetry operation 43.1400000000 85.7400000000 0.0000000000 A O SER 23 A O SER 23 A N ASP 18 A N ASP 18 A N MET 13 A N MET 13 A O TYR 105 A O TYR 105 A N SER 112 A N SER 112 A O SER 115 A O SER 115 A N THR 118 A N THR 118 B O TYR 116 B O TYR 116 B O THR 123 B O THR 123 B N ARG 104 B N ARG 104 B O TYR 105 B O TYR 105 B N MET 13 B N MET 13 B N ASP 18 B N ASP 18 B O SER 23 B O SER 23 A N LEU 55 A N LEU 55 A O VAL 14 A O VAL 14 A N MET 13 A N MET 13 A O TYR 105 A O TYR 105 A N SER 112 A N SER 112 A O SER 115 A O SER 115 A N THR 118 A N THR 118 B O TYR 116 B O TYR 116 B O THR 123 B O THR 123 B N ARG 104 B N ARG 104 B O TYR 105 B O TYR 105 B N MET 13 B N MET 13 B O VAL 14 B O VAL 14 B N LEU 55 B N LEU 55 A O GLY 47 A O GLY 47 A N VAL 30 A N VAL 30 A N LYS 35 A N LYS 35 A O ILE 68 A O ILE 68 A N ILE 73 A N ILE 73 A O ALA 91 A O ALA 91 A O VAL 94 A O VAL 94 B N GLU 89 B N GLU 89 B N ALA 97 B N ALA 97 B O GLY 67 B O GLY 67 B N GLU 72 B N GLU 72 B O HIS 31 B O HIS 31 B O ARG 34 B O ARG 34 B N GLU 42 B N GLU 42 1 B DIF 125 C DIF 1 A GLY 1 A GLY 1 1 Y 1 A PRO 2 A PRO 2 1 Y 1 A THR 3 A THR 3 1 Y 1 A GLY 4 A GLY 4 1 Y 1 A THR 5 A THR 5 1 Y 1 A GLY 6 A GLY 6 1 Y 1 A GLU 7 A GLU 7 1 Y 1 A SER 8 A SER 8 1 Y 1 A LYS 9 A LYS 9 1 Y 1 B GLY 1 B GLY 1 1 Y 1 B PRO 2 B PRO 2 1 Y 1 B THR 3 B THR 3 1 Y 1 B GLY 4 B GLY 4 1 Y 1 B THR 5 B THR 5 1 Y 1 B GLY 6 B GLY 6 1 Y 1 B GLU 7 B GLU 7 1 Y 1 B SER 8 B SER 8 1 Y 1 B LYS 9 B LYS 9 1 Y 1 B ASN 124 B ASN 124 1 Y 1 B ASP 99 65.15 63.70 1 B PRO 102 -54.73 105.42 The structure contains two diclofenac molecules that bind in each of two independent binding sites of the tetramer. Since the binding is along the 2-fold crystallographic axis, an occupancy of 0.5 corresponds to saturation of each of the binding sites. Binding of diclofenac in two symmetry-related binding modes induces alternate side chain conformations for the protein residues Val17, Ser117, and Thr119. 0.2150000 0.1920000 2 8 1590 16078 15655 95.0 randomly chosen subset of 10 % of the observed reflections 1 2 Engh & Huber 2 8 52 1842 19 0 1771 1.260 0.006 2 20 1DVX 16154 16154 0 0 0.0860000 1 9.9 4.48 97.1 0.2170000 1.9 2.0 1 90.5 refinement CNS data reduction DENZO data scaling SCALEPACK phasing CNS TRANSTHYRETIN / DICLOFENAC COMPLEX CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC 1 N N 1 N N 2 N N 3 N N 3 N N The biological assembly is a tetramer constructed from the homodimer (chain A and B) and a symmetry mate generated by the two-fold A ASP 74 A ASP 74 HELX_P A LEU 82 A LEU 82 1 1 9 B ASP 74 B ASP 74 HELX_P B LEU 82 B LEU 82 1 2 9 covale 2.028 A A B DIF 125 C CL4 DIF 1_555 A LEU 17 A CD1 LEU 17 2_665 HORMONE/GROWTH FACTOR THYROXINE TRANSPORT, SIGNALING PROTEIN, HORMONE-GROWTH FACTOR COMPLEX TTHY_HUMAN UNP 1 1 P02766 GPTGTGESKCPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWK ALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN 1 124 1DVX 1 124 P02766 A 1 1 124 1 124 1DVX 1 124 P02766 B 1 1 124 8 8 8 anti-parallel parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A SER 23 A SER 23 A PRO 24 A PRO 24 A LEU 12 A LEU 12 A ASP 18 A ASP 18 A ARG 104 A ARG 104 A SER 112 A SER 112 A SER 115 A SER 115 A THR 123 A THR 123 B SER 115 B SER 115 B THR 123 B THR 123 B ARG 104 B ARG 104 B SER 112 B SER 112 B LEU 12 B LEU 12 B ASP 18 B ASP 18 B SER 23 B SER 23 B PRO 24 B PRO 24 A GLU 54 A GLU 54 A LEU 55 A LEU 55 A LEU 12 A LEU 12 A ASP 18 A ASP 18 A ARG 104 A ARG 104 A SER 112 A SER 112 A SER 115 A SER 115 A THR 123 A THR 123 B SER 115 B SER 115 B THR 123 B THR 123 B ARG 104 B ARG 104 B SER 112 B SER 112 B LEU 12 B LEU 12 B ASP 18 B ASP 18 B GLU 54 B GLU 54 B LEU 55 B LEU 55 A TRP 41 A TRP 41 A LYS 48 A LYS 48 A ALA 29 A ALA 29 A LYS 35 A LYS 35 A GLY 67 A GLY 67 A ILE 73 A ILE 73 A HIS 88 A HIS 88 A ALA 97 A ALA 97 B HIS 88 B HIS 88 B ALA 97 B ALA 97 B GLY 67 B GLY 67 B ILE 73 B ILE 73 B ALA 29 B ALA 29 B LYS 35 B LYS 35 B TRP 41 B TRP 41 B LYS 48 B LYS 48 BINDING SITE FOR RESIDUE DIF B 125 Software 25 A LYS 15 A LYS 15 25 2_665 A LEU 17 A LEU 17 25 2_665 A LEU 17 A LEU 17 25 1_555 A ALA 108 A ALA 108 25 1_555 A ALA 108 A ALA 108 25 2_665 A ALA 109 A ALA 109 25 2_665 A LEU 110 A LEU 110 25 2_665 A LEU 110 A LEU 110 25 1_555 A SER 117 A SER 117 25 2_665 A SER 117 A SER 117 25 1_555 A THR 118 A THR 118 25 1_555 A THR 119 A THR 119 25 1_555 B LYS 15 B LYS 15 25 2_665 B LEU 17 B LEU 17 25 2_665 B LEU 17 B LEU 17 25 1_555 B ALA 108 B ALA 108 25 1_555 B ALA 108 B ALA 108 25 2_665 B LEU 110 B LEU 110 25 2_665 B LEU 110 B LEU 110 25 1_555 B SER 117 B SER 117 25 2_665 B SER 117 B SER 117 25 1_555 B THR 118 B THR 118 25 1_555 B THR 119 B THR 119 25 2_665 B THR 119 B THR 119 25 1_555 B VAL 121 B VAL 121 25 1_555 18 P 21 21 2